Korro Bio, Inc. Realized Investment Gains (Losses)
Korro Bio, Inc. (KRRO) reported Realized Investment Gains (Losses) of $3.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2023-03-10
- Korro Bio, Inc. realized investment gains (losses) for the quarter ending 2022-12-31 was $0.00.
- Korro Bio, Inc. realized investment gains (losses) for the quarter ending 2022-09-30 was $1.00K.
- Korro Bio, Inc. realized investment gains (losses) for the quarter ending 2022-06-30 was $2.00K.
- Korro Bio, Inc. realized investment gains (losses) for the quarter ending 2022-03-31 was $0.00.
- Korro Bio, Inc. realized investment gains (losses) for fiscal 2022 was $3.00K.
- Korro Bio, Inc. realized investment gains (losses) for fiscal 2021 was -$23.00K, a 127.38% decline from fiscal 2020.
- Korro Bio, Inc. realized investment gains (losses) for fiscal 2020 was $84.00K, a 39.13% decline from fiscal 2019.
- Korro Bio, Inc. realized investment gains (losses) for fiscal 2019 was $138.00K.
| Period end | Realized Investment Gains (Losses) 3 month | Realized Investment Gains (Losses) 6 month | Realized Investment Gains (Losses) 9 month | Realized Investment Gains (Losses) 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $1.00K derived: sum of 2 quarters · filed 2023-03-10 | $3.00K derived: sum of 3 quarters · filed 2023-03-10 | $3.00K 10-K · filed 2023-03-10 |
| 2022-09-30 | $1.00K 10-Q · filed 2022-11-08 | $3.00K derived: sum of 2 quarters · filed 2022-11-08 | $3.00K 10-Q · filed 2022-11-08 | $3.00K derived: sum of 4 quarters · filed 2023-03-10 |
| 2022-06-30 | $2.00K 10-Q · filed 2022-08-09 | $2.00K 10-Q · filed 2022-08-09 | $2.00K derived: sum of 3 quarters · filed 2023-03-10 | -$7.00K derived: sum of 4 quarters · filed 2023-03-10 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2023-03-10 | -$9.00K derived: sum of 3 quarters · filed 2023-03-10 | -$19.00K derived: sum of 4 quarters · filed 2023-03-10 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | -$9.00K derived: sum of 2 quarters · filed 2023-03-10 | -$19.00K derived: sum of 3 quarters · filed 2023-03-10 | -$23.00K 10-K · filed 2023-03-10 |
| 2021-09-30 | -$9.00K 10-Q · filed 2022-11-08 | -$19.00K derived: sum of 2 quarters · filed 2022-11-08 | -$23.00K 10-Q · filed 2022-11-08 | -$4.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$10.00K 10-Q · filed 2022-08-09 | -$14.00K 10-Q · filed 2022-08-09 | $5.00K derived: sum of 3 quarters · filed 2022-08-09 | $5.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$4.00K 10-Q · filed 2022-05-04 | $15.00K derived: sum of 2 quarters · filed 2022-05-04 | $15.00K derived: sum of 3 quarters · filed 2022-05-04 | $11.00K derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $19.00K derived: sum of 2 quarters · filed 2022-03-15 | $15.00K derived: sum of 3 quarters · filed 2022-03-15 | $84.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$4.00K derived: sum of 2 quarters · filed 2021-11-15 | $65.00K 10-Q · filed 2021-11-15 | $115.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$4.00K 10-Q · filed 2021-08-12 | $65.00K 10-Q · filed 2021-08-12 | $115.00K derived: sum of 3 quarters · filed 2021-08-12 | $177.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $69.00K 10-Q · filed 2021-05-13 | $119.00K derived: sum of 2 quarters · filed 2021-05-13 | $181.00K derived: sum of 3 quarters · filed 2021-05-13 | $207.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $112.00K derived: sum of 2 quarters · filed 2021-03-29 | $138.00K derived: sum of 3 quarters · filed 2021-03-29 | $138.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $62.00K 10-Q · filed 2020-11-16 | $88.00K derived: sum of 2 quarters · filed 2020-11-16 | $88.00K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $26.00K 10-Q · filed 2020-08-12 | $26.00K 10-Q · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |